Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SLNO
#1669
Soleno Therapeutics, Inc. Common Stock
39.0
7
+5.51%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+5.51%
Monthly Change
-9.20%
6 month change
-42.34%
Cambio anual
-13.27%
Cierres anteriores
37.0
3
Open
39.0
7
Bid
Ask
Low
39.0
7
High
39.0
7
Volumen
143
Markets
Acciones
Atención Sanitaria
SLNO
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
Noticias
Las acciones de Soleno Therapeutics alcanzan mínimos de 52 semanas en 36,01 dólares
Soleno Therapeutics stock hits 52-week low at 36.01 USD
Soleno Therapeutics nombra a Jennifer Fulk como directora financiera
Soleno Therapeutics names Jennifer Fulk as CFO
Soleno Therapeutics earnings beat by $0.19, revenue topped estimates
Soleno Therapeutics enfrenta prueba de resultados mientras se examinan métricas de lanzamiento
Soleno Therapeutics faces earnings test as launch metrics scrutinized
Las acciones de Soleno Therapeutics caen a mínimos de 52 semanas a 37,95 dólares
Soleno Therapeutics stock hits 52-week low at 37.95 USD
Ultragenyx Pharmaceutical Resubmits UX111 BLA for Sanfilippo Syndrome
Down 18.3% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround
FDA Accepts SMMT's Application Seeking Approval for NSCLC Drug